PI11298 5-Aminoorotic Acid (CAS No.: 7164-43-4)

5-Aminoorotic Acid (CAS No.: 7164-43-4) Description

5-Aminoorotic Acid (C5H5N3O4, CAS 7164-43-4) functions as a pharmaceutical intermediate in organic synthesis. Its amino-substituted orotic acid structure provides a defined reactivity profile, enabling effective incorporation into heterocyclic compound synthesis. The powder form allows for precise dosing and ease of handling during chemical transformations, facilitating reproducible outcomes in medicinal chemistry applications.

5-Aminoorotic Acid (CAS No.: 7164-43-4) Applications

1.         Pharmaceutical Synthesis Applications
   - Used as an intermediate in heterocyclic compound synthesis to achieve efficient ring formation by leveraging its specific reactivity profile.
   - Applied in modification reactions for the development of nucleobase analogues to facilitate targeted molecular assembly.

2.         Research Applications
   - Serves as a reagent in studies on nucleotide metabolism pathways to explore biochemical interactions by leveraging its amino functionality.
   - Utilised in organic synthesis research laboratories for method development, aiding in the refinement of synthetic strategies through its reproducible chemical behaviour.

5-Aminoorotic Acid (CAS No.: 7164-43-4) Packing

5-Aminoorotic Acid is packaged in sealed, moisture-resistant containers with batch-specific labelling. The packaging employs inert, anti-static materials to prevent contamination during transportation and storage. Recommended storage conditions include a cool, dry environment to preserve chemical integrity. Options for customised packaging, such as additional protective inserts and temperature-controlled solutions, are available upon request to meet specific handling requirements.

Additional Information

5-Aminoorotic Acid falls within a class of nitrogen-containing heterocyclic compounds that serve as key intermediates in the synthesis of complex pharmaceutical agents. Its chemical structure facilitates the formation of diverse heterocyclic systems, which are foundational in medicinal chemistry research. Researchers utilise these intermediates to construct molecular architectures that can be further functionalised for therapeutic applications.

Understanding the chemical behaviour of intermediates like 5-Aminoorotic Acid is essential for optimising reaction conditions and achieving reproducible synthetic outcomes. Advances in analytical methods, coupled with rigorous process controls, contribute to the ongoing development of effective and scalable synthesis routes in pharmaceutical production.